Genotyping Sample Collection System

The system will facilitate the routine use of genetic analysis to prescribe a particular drug for a particular patient in personalized medicine and will also aid the use of genetic analysis in drug development.

SAFEspot is based on a proprietary adsorbent matrix. Past genotyping studies have used liquid blood as the source of genetic material, but collecting venous blood requires trained staff and can be unpleasant for patients. In contrast, SAFEspot uses a single finger stick blood sample, which makes collection painless. The dried blood sample is stable, sterile, and safe, and can be shipped at ambient temperature rather than frozen. Sufficient DNA can be captured from each card for more than 200 separate single nucleotide polymorphisms (SNPs), micro-satellite, or other genetic analyses. SAFEspot was developed by DxS Ltd. (Manchester, UK).

"The fast, effortless collection and shipment of safe and stable samples has convinced DxS to recommend Safespot in the collection of blood samples for the genotyping services we provide to our pharmaceutical, biotechnology, and other customers,” said Dr. Steve Little, CEO of DxS.

The DxS service is based on proprietary Scorpions technology that allows rapid and reliable polymerase chain reaction (PCR)-based genotyping. Genotyping analyses for personalized medicine would be further facilitated by a global network of accredited laboratories that would operate in partnership with a pharmaceutical company to provide local pharmacogenetic testing.




Related Links:
DxS